These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18422475)

  • 1. Managing neuropathic pain with Sativex: a review of its pros and cons.
    Perez J; Ribera MV
    Expert Opin Pharmacother; 2008 May; 9(7):1189-95. PubMed ID: 18422475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soya supplements in the treatment of neuropathic pain].
    Bermejo PE
    Rev Neurol; 2007 Oct 16-31; 45(8):479-81. PubMed ID: 17948214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
    Russo EB; Guy GW; Robson PJ
    Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence.
    Granot R; Day RO; Cohen ML; Murnion B; Garrick R
    Pain Med; 2007; 8(1):48-64. PubMed ID: 17244104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide for the treatment of diabetic neuropathic pain.
    Biton V
    Expert Rev Neurother; 2008 Nov; 8(11):1649-60. PubMed ID: 18986235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
    Edelsberg J; Oster G
    Eur J Pain; 2009 Jan; 13(1):11-6. PubMed ID: 18456524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic pain: are we out of the woods yet?
    Cavenagh J; Good P; Ravenscroft P
    Intern Med J; 2006 Apr; 36(4):251-5. PubMed ID: 16640743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxycodone and the challenge of neuropathic cancer pain: a review.
    Núñez Olarte JM
    Oncology; 2008; 74 Suppl 1():83-90. PubMed ID: 18758204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in the management of neuropathic pain.
    McCleane G
    Expert Rev Neurother; 2005 Sep; 5(5):617-23. PubMed ID: 16162085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant analgesics in neuropathic pain.
    Kong VK; Irwin MG
    Eur J Anaesthesiol; 2009 Feb; 26(2):96-100. PubMed ID: 19142081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathic pain. Basic principles for successful therapy].
    Tölle TR; Baron R
    MMW Fortschr Med; 2002 May; 144(21):41-4. PubMed ID: 12134424
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabis and its derivatives: review of medical use.
    Leung L
    J Am Board Fam Med; 2011; 24(4):452-62. PubMed ID: 21737770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of neuropathic pain.
    Jensen TS; Finnerup NB
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):126-31. PubMed ID: 18685353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of pain in multiple sclerosis.
    Solaro C; Tanganelli P; Messmer Uccelli M
    Expert Rev Neurother; 2007 Sep; 7(9):1165-74. PubMed ID: 17868015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy.
    Guastella V; Mick G
    Diabetes Metab; 2009 Feb; 35(1):12-9. PubMed ID: 19046917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
    Wade D
    Expert Rev Neurother; 2012 Apr; 12(4 Suppl):9-14. PubMed ID: 22509986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic pain: evidence matters.
    McQuay HJ
    Eur J Pain; 2002; 6 Suppl A():11-8. PubMed ID: 11888235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.